Description
An inhibitor of RSV; binds to RSV nucleoprotein (Kd = 1.31 μM); reduces plaque formation by RSS, Long, A2, and B RSV strains (EC50s = 0.9, 0.8, 0.5, and 0.6 μM, respectively); active against 40 RSV clinical isolates (mean EC50 = 0.8 μM); increases viability of RSV-infected HEp-2 cells (EC50 = 0.86 μM); inhibits RSV replication in HAE cell monolayers following mucosal inoculation
Formal name: N-[(3S)-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N′-(2-fluorophenyl)-urea
Synonyms:
Molecular weight: 388.4
CAS: 676128-63-5
Purity: ≥98%
Formulation: A solid